BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 36114510)

  • 1. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
    Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
    J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs regulating epithelial-mesenchymal transition: Research progress in liver disease.
    Yang X; Jiang Z; Li Y; Zhang Y; Han Y; Gao L
    Biomed Pharmacother; 2022 Jun; 150():112972. PubMed ID: 35447551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs and potential therapeutic targeting in cancer.
    Toden S; Zumwalt TJ; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188491. PubMed ID: 33316377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs regulate tumor cell plasticity.
    Liu B; Sun L; Song E
    Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.
    Chen Y; Lu L; Feng B; Han S; Cui S; Chu X; Chen L; Wang R
    Oncotarget; 2017 May; 8(22):36787-36799. PubMed ID: 28415568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.
    Jawad SF; Altalbawy FMA; Hussein RM; Fadhil AA; Jawad MA; Zabibah RS; Taraki TY; Mohan CD; Rangappa KS
    Cancer Metastasis Rev; 2024 Mar; 43(1):5-27. PubMed ID: 37552389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs in cataract formation: Star molecules emerge in an endless stream.
    Chen S; Zhang C; Shen L; Hu J; Chen X; Yu Y
    Pharmacol Res; 2022 Oct; 184():106417. PubMed ID: 36038044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
    Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
    Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).
    Ding XM
    Chin J Cancer; 2014 Mar; 33(3):140-7. PubMed ID: 24016392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.
    Li W; Han Y; Sun C; Li X; Zheng J; Che J; Yao X; Kufe D
    Theranostics; 2022; 12(3):999-1011. PubMed ID: 35154471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.
    Yamaguchi K; Yamamoto T; Chikuda J; Shirota T; Yamamoto Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mesenchymal phenotype by MicroRNAs in cancer.
    Yan J; Gumireddy K; Li A; Huang Q
    Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNA in cancer.
    Yan H; Bu P
    Essays Biochem; 2021 Oct; 65(4):625-639. PubMed ID: 33860799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells.
    Mahmoudian RA; Akhlaghipour I; Lotfi M; Shahidsales S; Moghbeli M
    Pathol Res Pract; 2023 May; 245():154472. PubMed ID: 37087995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small nucleolar RNA host genes promoting epithelial-mesenchymal transition lead cancer progression and metastasis.
    Biagioni A; Tavakol S; Ahmadirad N; Zahmatkeshan M; Magnelli L; Mandegary A; Samareh Fekri H; Asadi MH; Mohammadinejad R; Ahn KS
    IUBMB Life; 2021 Jun; 73(6):825-842. PubMed ID: 33938625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential.
    Beňačka R; Szabóová D; Guľašová Z; Hertelyová Z; Radoňak J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
    Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
    Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
    Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.